| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| px-12 | thioredoxin | NA | Clinical trial target | TTD , DGIDB | Malignant neoplasm of stomach[MeSHID:D013274] Neoplasms[MeSHID:D009369] Malignant neoplasm of pancreas[MeSHID:D010190] Pancreatic carcinoma[MeSHID:C562463] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] |
31.83 | phase 2 | unknown |
| px-12 | thioredoxin | NA | Clinical trial target | TTD , DGIDB | Malignant neoplasm of stomach[MeSHID:D013274] Neoplasms[MeSHID:D009369] Malignant neoplasm of pancreas[MeSHID:D010190] Pancreatic carcinoma[MeSHID:C562463] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
31.83 | phase 2 | unknown |
| px-12 | thioredoxin reductase 1, cytoplasmic | small molecule | NA | drugbank | Malignant neoplasm of stomach[MeSHID:D013274] Neoplasms[MeSHID:D009369] Malignant neoplasm of pancreas[MeSHID:D010190] Pancreatic carcinoma[MeSHID:C562463] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
NA | investigational | unknown |
| px-12 | thioredoxin reductase 1, cytoplasmic | small molecule | NA | drugbank | Malignant neoplasm of stomach[MeSHID:D013274] Neoplasms[MeSHID:D009369] Malignant neoplasm of pancreas[MeSHID:D010190] Pancreatic carcinoma[MeSHID:C562463] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] |
NA | investigational | unknown |
| click here to return to the previous page | ||||||||